Drug Patents owned by Gilead Sciences Inc

1. Drug name - BIKTARVY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7390791 GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US9296769 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US8754065 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US9732092 GILEAD SCIENCES INC Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections
Dec, 2033

(11 years from now)

US9216996 GILEAD SCIENCES INC Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
Dec, 2033

(11 years from now)

US9708342 GILEAD SCIENCES INC Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olate
Jun, 2035

(12 years from now)

CN101796040A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN110563747A GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2022

(3 months ago)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

CN101679325B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103435570A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103275033A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B GILEAD SCIENCES INC Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN101679325A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN107674086A GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN104995198A GILEAD SCIENCES INC Polycyclic - Carbamoyl-Pyridone Compounds And Pharmaceutical Use
Dec, 2033

(11 years from now)

CN104995198B GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN107674086B GILEAD SCIENCES INC Polycyclic-Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN106459085A GILEAD SCIENCES INC (2R, 5S, 13Ar) -7, 9 - -10-((2, 4, 6-Trifluoro-Benzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A - -2, 5-Pyridine Methylene Bridge (1 ', 2 ': 4, 5] Pyridine [2, 1-B] [1, 3] * -8 - Sodium Phenolate
Jun, 2035

(12 years from now)

CN106459085B GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2035

(12 years from now)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

IN332719B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN352932B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201918019286A GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201505535P1 GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN371130B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP3112355A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487161B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP2170851B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP3067358A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3067358B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3157932A1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

EP3157932B1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7390791

(Pediatric)

GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues Oct, 2025

(3 years from now)

US9296769

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US8754065

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US10385067 GILEAD SCIENCES INC Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate Jun, 2035

(12 years from now)

US10548846 GILEAD SCIENCES INC Therapeutic compositions for treatment of human immunodeficiency virus Nov, 2036

(14 years from now)

More Information on Dosage
Strength Dosage Availability
EQ 30MG BASE;120MG;EQ 15MG BASE TABLET;ORAL Prescription
EQ 50MG BASE;200MG;EQ 25MG BASE TABLET;ORAL Prescription

2. Drug name - COMPLERA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8080551 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2023

(6 months from now)

US7125879 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2025

(2 years from now)

CN101056673A GILEAD SCIENCES INC 4-[[4-[[4-(2-Cyanovinyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidyl]Amino] Benzonitrile Hydrochloride
Jun, 2015

(7 years ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN101816658B GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN101816658A GILEAD SCIENCES INC Pyramine Derivatives For Inhibiting Hiv
Aug, 2022

(a month ago)

CN1541215A GILEAD SCIENCES INC Hiv Inhibiting Pyrimidine Derivatives
Aug, 2022

(a month ago)

CN100509801C GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN101068597B GILEAD SCIENCES INC 4 - ((4 - ((4 - (2) -2, 6 -) Dimethylphenyl Amido) -2 - Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 11 months from now)

CN101060844B GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Sep, 2024

(1 year, 11 months from now)

CN101068597A GILEAD SCIENCES INC Fumaric Acid Salt Of 4-((4-((4-(2-Cyanovinyl)-2, 6-) Dimethylphenyl Amido)-2- Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 11 months from now)

CN101060844A GILEAD SCIENCES INC Composition Of Rt Inhibitor And Nnrti Containing Pyrimidine
Sep, 2024

(1 year, 11 months from now)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN222987B GILEAD SCIENCES INC A Pyrimidine Compound Of Formula (I)
Aug, 2022

(a month ago)

IN200400265P1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP1663240A1 GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP1663240B1 GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1632232B1 GILEAD SCIENCES INC Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP1632232A1 GILEAD SCIENCES INC Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP3808743A1 GILEAD SCIENCES INC Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761A1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP3808743B1 GILEAD SCIENCES INC Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761B1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP1789139A1 GILEAD SCIENCES INC Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1789139B1 GILEAD SCIENCES INC Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1419152B1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

EP1419152A1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9744181 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US8716264 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US9457036 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US8592397 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US8841310 GILEAD SCIENCES INC Combinations of a pyrimidine containing NNRTI with RT inhibitors Dec, 2025

(3 years from now)

US10857102 GILEAD SCIENCES INC Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate Jan, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
200MG;EQ 25MG BASE;300MG TABLET;ORAL Prescription

3. Drug name - DESCOVY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7390791 GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US9296769 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US8754065 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN101796040A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN110563747A GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2022

(3 months ago)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

CN101679325B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103435570A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103275033A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B GILEAD SCIENCES INC Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN101679325A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN107674086A GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN104995198A GILEAD SCIENCES INC Polycyclic - Carbamoyl-Pyridone Compounds And Pharmaceutical Use
Dec, 2033

(11 years from now)

CN104995198B GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN107674086B GILEAD SCIENCES INC Polycyclic-Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN106459085A GILEAD SCIENCES INC (2R, 5S, 13Ar) -7, 9 - -10-((2, 4, 6-Trifluoro-Benzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A - -2, 5-Pyridine Methylene Bridge (1 ', 2 ': 4, 5] Pyridine [2, 1-B] [1, 3] * -8 - Sodium Phenolate
Jun, 2035

(12 years from now)

CN106459085B GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2035

(12 years from now)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

IN332719B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN352932B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201918019286A GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201505535P1 GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN371130B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP3112355A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487161B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP2170851B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP3067358A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3067358B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3157932A1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

EP3157932B1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7390791

(Pediatric)

GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues Oct, 2025

(3 years from now)

US9296769

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US8754065

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
120MG;EQ 15MG BASE TABLET;ORAL Prescription
200MG;EQ 25MG BASE TABLET;ORAL Prescription

4. Drug name - EPCLUSA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8580765 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8334270 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US9085573 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8633309 GILEAD SCIENCES INC Nucleoside phosphoramidates
Mar, 2029

(6 years from now)

US7964580 GILEAD SCIENCES INC NA
Mar, 2029

(6 years from now)

US9284342 GILEAD SCIENCES INC Nucleoside phosphoramidates
Sep, 2030

(7 years from now)

US8618076 GILEAD SCIENCES INC Nucleoside phosphoramidates
Dec, 2030

(8 years from now)

US8575135 GILEAD SCIENCES INC Antiviral compounds
Nov, 2032

(10 years from now)

US8921341 GILEAD SCIENCES INC Antiviral compounds
Nov, 2032

(10 years from now)

US8940718 GILEAD SCIENCES INC Antiviral compounds
Nov, 2032

(10 years from now)

CN102906102A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus-Containing Active Matter
Nov, 2015

(6 years ago)

CN104144682A GILEAD SCIENCES INC A Combined Preparation Of Two Antiviral Compounds
Oct, 2016

(5 years ago)

CN104292256A GILEAD SCIENCES INC N - [(2 ' R) -2 '--2 '--2 ' - Methyl-Beta-Phenyl - -5 ' - Uridine Acyl] -L - Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
Nov, 2018

(3 years ago)

CN105198949A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Its Preparation Method
Dec, 2019

(2 years ago)

CN104211713B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN104230900B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN104211689A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104016971B GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104211713A GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN104211689B GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104230900A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104016971A GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN102596936A GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN103977406A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN103977406B GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN106588890B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN102596936B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN106588890A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN102459299A GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' - Fluoro-2'-Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine-1-Methylethyl Ester Process For Its Production
May, 2030

(7 years from now)

CN102459299B GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' -Fluoro-2 ' -Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine 1-Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

CN105085592B GILEAD SCIENCES INC N - [(2 ' R) - 2 ' - Deoxy-2 ' - Fluorine-2 ' - Methyl-Beta-Phenyl-5 ' - Uridine Acyl] -L - Lactamine 1-Methyl Ethyl Ester And Its Preparation Method
May, 2030

(7 years from now)

CN105085592A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
May, 2030

(7 years from now)

CN104017020B GILEAD SCIENCES INC Nucleoside Phosphoramidate
Mar, 2031

(8 years from now)

CN104017020A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

CN103328480A GILEAD SCIENCES INC A Imidazole Imidazole For Condensation Of Antiviral Composition
Nov, 2032

(10 years from now)

CN103328480B GILEAD SCIENCES INC Condensed Imidazolyl-Imidazole As Antiviral Compound
Nov, 2032

(10 years from now)

CN105837584B GILEAD SCIENCES INC Condensation Of Imidazole Imidazole As Antivirus Compound
Nov, 2032

(10 years from now)

CN105837584A GILEAD SCIENCES INC Condensed Imidazolyl-Imidazole As Antiviral Compound
Nov, 2032

(10 years from now)

CN105748499A GILEAD SCIENCES INC Coupling Preparation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

CN105748499B GILEAD SCIENCES INC A Combined Preparation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

IN346815B GILEAD SCIENCES INC N-[ (2&Amp;Apos;R) -2&Amp;Apos; Deoxy-2&Amp;Apos;- Fluoro-2&Amp;Apos;-Methyl-Pphenyl- 5&Amp;Apos;-Uridylyl] -L-Alanine 1- Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

EP2203462B1 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2203462A2 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2826784A1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP2826784B1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP2873665B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP2873665A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3309157A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3309157B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3002281A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3002281B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP2430014A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP2430014B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3321275A1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2913337A1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP3321275B1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2432792B1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2432792A1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2913337B1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP2609923A3 GILEAD SCIENCES INC Nucleoside Phosphoramidates
Mar, 2031

(8 years from now)

EP3290428B1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552930B1 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552931A2 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552930A2 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422A1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552931B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923B1 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923A2 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP3290428A1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2640719A2 GILEAD SCIENCES INC Antiviral Compounds
Nov, 2031

(9 years from now)

EP2640719B1 GILEAD SCIENCES INC Antiviral Compounds
Nov, 2031

(9 years from now)

EP3431477A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP3431477B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2907816B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2635588A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2907816A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2635588B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2950786A1 GILEAD SCIENCES INC Combination Formulation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

EP2950786B1 GILEAD SCIENCES INC Combination Formulation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8735372 GILEAD SCIENCES INC NA Mar, 2028

(5 years from now)

US9085573

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8334270

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8735372

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8580765

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8889159 GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Mar, 2029

(6 years from now)

US7964580

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2029

(6 years from now)

US8889159

(Pediatric)

GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Sep, 2029

(6 years from now)

US8633309

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Sep, 2029

(6 years from now)

US9284342

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Mar, 2031

(8 years from now)

US8618076

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Jun, 2031

(8 years from now)

US8940718

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds May, 2033

(10 years from now)

US8921341

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds May, 2033

(10 years from now)

US8575135

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds May, 2033

(10 years from now)

US11116783 GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jan, 2034

(11 years from now)

US10086011 GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jan, 2034

(11 years from now)

US9757406 GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jan, 2034

(11 years from now)

US11116783

(Pediatric)

GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jul, 2034

(11 years from now)

US9757406

(Pediatric)

GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jul, 2034

(11 years from now)

US10086011

(Pediatric)

GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jul, 2034

(11 years from now)

Drugs and Companies using SOFOSBUVIR; VELPATASVIR ingredient

Treatment: For the treatment of hepatitis c

Dosage: PELLETS;ORAL

More Information on Dosage
Strength Dosage Availability
150MG;37.5MG/PACKET PELLETS;ORAL Prescription
200MG;50MG/PACKET PELLETS;ORAL Prescription

5. Drug name - GENVOYA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7390791 GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US7176220 GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent
Aug, 2026

(3 years from now)

US7635704 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US8981103 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US8148374 GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

US9296769 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US8754065 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN101796040A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN110563747A GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2022

(3 months ago)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

CN101679325B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103435570A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103275033A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B GILEAD SCIENCES INC Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN101679325A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN107674086A GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN104995198A GILEAD SCIENCES INC Polycyclic - Carbamoyl-Pyridone Compounds And Pharmaceutical Use
Dec, 2033

(11 years from now)

CN104995198B GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN107674086B GILEAD SCIENCES INC Polycyclic-Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN106459085A GILEAD SCIENCES INC (2R, 5S, 13Ar) -7, 9 - -10-((2, 4, 6-Trifluoro-Benzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A - -2, 5-Pyridine Methylene Bridge (1 ', 2 ': 4, 5] Pyridine [2, 1-B] [1, 3] * -8 - Sodium Phenolate
Jun, 2035

(12 years from now)

CN106459085B GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2035

(12 years from now)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

IN332719B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN352932B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201918019286A GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201505535P1 GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN371130B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP3112355A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487161B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP2170851B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP3067358A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3067358B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3157932A1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

EP3157932B1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7390791

(Pediatric)

GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues Oct, 2025

(3 years from now)

US7176220

(Pediatric)

GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent Feb, 2027

(4 years from now)

US7635704

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US8981103

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US9891239 GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Sep, 2029

(6 years from now)

US9891239

(Pediatric)

GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Mar, 2030

(7 years from now)

US8148374

(Pediatric)

GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Mar, 2030

(7 years from now)

US8633219 GILEAD SCIENCES INC Combination therapy Apr, 2030

(7 years from now)

US8633219

(Pediatric)

GILEAD SCIENCES INC Combination therapy Oct, 2030

(8 years from now)

US10039718 GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

US9296769

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US8754065

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US10039718

(Pediatric)

GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Apr, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
150MG;150MG;200MG;EQ 10MG BASE TABLET;ORAL Prescription

6. Drug name - HARVONI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8580765 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8334270 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US9085573 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8633309 GILEAD SCIENCES INC Nucleoside phosphoramidates
Mar, 2029

(6 years from now)

US7964580 GILEAD SCIENCES INC NA
Mar, 2029

(6 years from now)

US8822430 GILEAD SCIENCES INC Antiviral compounds
May, 2030

(7 years from now)

US8088368 GILEAD SCIENCES INC Antiviral compounds
May, 2030

(7 years from now)

US9284342 GILEAD SCIENCES INC Nucleoside phosphoramidates
Sep, 2030

(7 years from now)

US8618076 GILEAD SCIENCES INC Nucleoside phosphoramidates
Dec, 2030

(8 years from now)

US10039779 GILEAD SCIENCES INC Combination formulation of two antiviral compounds
Jan, 2034

(11 years from now)

CN102906102A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus-Containing Active Matter
Nov, 2015

(6 years ago)

CN104144682A GILEAD SCIENCES INC A Combined Preparation Of Two Antiviral Compounds
Oct, 2016

(5 years ago)

CN104292256A GILEAD SCIENCES INC N - [(2 ' R) -2 '--2 '--2 ' - Methyl-Beta-Phenyl - -5 ' - Uridine Acyl] -L - Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
Nov, 2018

(3 years ago)

CN105198949A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Its Preparation Method
Dec, 2019

(2 years ago)

CN104211713B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN104230900B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN104211689A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104016971B GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104211713A GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN104211689B GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104230900A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN104016971A GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN102596936A GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN103977406A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN103977406B GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN106588890B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN102596936B GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

CN106588890A GILEAD SCIENCES INC Antiviral Compound
May, 2030

(7 years from now)

CN102459299A GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' - Fluoro-2'-Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine-1-Methylethyl Ester Process For Its Production
May, 2030

(7 years from now)

CN102459299B GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' -Fluoro-2 ' -Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine 1-Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

CN105085592B GILEAD SCIENCES INC N - [(2 ' R) - 2 ' - Deoxy-2 ' - Fluorine-2 ' - Methyl-Beta-Phenyl-5 ' - Uridine Acyl] -L - Lactamine 1-Methyl Ethyl Ester And Its Preparation Method
May, 2030

(7 years from now)

CN105085592A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
May, 2030

(7 years from now)

CN104017020B GILEAD SCIENCES INC Nucleoside Phosphoramidate
Mar, 2031

(8 years from now)

CN104017020A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

CN103328480A GILEAD SCIENCES INC A Imidazole Imidazole For Condensation Of Antiviral Composition
Nov, 2032

(10 years from now)

CN103328480B GILEAD SCIENCES INC Condensed Imidazolyl-Imidazole As Antiviral Compound
Nov, 2032

(10 years from now)

CN105837584B GILEAD SCIENCES INC Condensation Of Imidazole Imidazole As Antivirus Compound
Nov, 2032

(10 years from now)

CN105837584A GILEAD SCIENCES INC Condensed Imidazolyl-Imidazole As Antiviral Compound
Nov, 2032

(10 years from now)

CN105748499A GILEAD SCIENCES INC Coupling Preparation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

CN105748499B GILEAD SCIENCES INC A Combined Preparation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

IN346815B GILEAD SCIENCES INC N-[ (2&Amp;Apos;R) -2&Amp;Apos; Deoxy-2&Amp;Apos;- Fluoro-2&Amp;Apos;-Methyl-Pphenyl- 5&Amp;Apos;-Uridylyl] -L-Alanine 1- Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

EP2203462B1 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2203462A2 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2826784A1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP2826784B1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP2873665B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP2873665A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3309157A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3309157B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3002281A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3002281B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP2430014A1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP2430014B1 GILEAD SCIENCES INC Antiviral Compounds
May, 2030

(7 years from now)

EP3321275A1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2913337A1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP3321275B1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2432792B1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2432792A1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2913337B1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP2609923A3 GILEAD SCIENCES INC Nucleoside Phosphoramidates
Mar, 2031

(8 years from now)

EP3290428B1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552930B1 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552931A2 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552930A2 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422A1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552931B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923B1 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923A2 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP3290428A1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2640719A2 GILEAD SCIENCES INC Antiviral Compounds
Nov, 2031

(9 years from now)

EP2640719B1 GILEAD SCIENCES INC Antiviral Compounds
Nov, 2031

(9 years from now)

EP3431477A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP3431477B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2907816B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2635588A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2907816A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2635588B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2950786A1 GILEAD SCIENCES INC Combination Formulation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

EP2950786B1 GILEAD SCIENCES INC Combination Formulation Of Two Antiviral Compounds
Jan, 2034

(11 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8735372 GILEAD SCIENCES INC NA Mar, 2028

(5 years from now)

US8735372

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8334270

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8580765

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US9085573

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8889159 GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Mar, 2029

(6 years from now)

US7964580

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2029

(6 years from now)

US8633309

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Sep, 2029

(6 years from now)

US8889159

(Pediatric)

GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Sep, 2029

(6 years from now)

US8273341 GILEAD SCIENCES INC Antiviral compounds May, 2030

(7 years from now)

US8841278 GILEAD SCIENCES INC Antiviral compounds May, 2030

(7 years from now)

US9511056 GILEAD SCIENCES INC Antiviral compounds May, 2030

(7 years from now)

US8822430

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds Nov, 2030

(8 years from now)

US8841278

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds Nov, 2030

(8 years from now)

US8273341

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds Nov, 2030

(8 years from now)

US9511056

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds Nov, 2030

(8 years from now)

US8088368

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds Nov, 2030

(8 years from now)

US9284342

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Mar, 2031

(8 years from now)

US8618076

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Jun, 2031

(8 years from now)

US9393256 GILEAD SCIENCES INC Methods for treating HCV Sep, 2032

(9 years from now)

US10456414 GILEAD SCIENCES INC Methods for treating HCV Sep, 2032

(9 years from now)

US9393256

(Pediatric)

GILEAD SCIENCES INC Methods for treating HCV Mar, 2033

(10 years from now)

US10039779

(Pediatric)

GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jul, 2034

(11 years from now)

Drugs and Companies using LEDIPASVIR; SOFOSBUVIR ingredient

Treatment: For the treatment of hepatitis c

Dosage: PELLETS;ORAL

More Information on Dosage
Strength Dosage Availability
33.75MG;150MG/PACKET PELLETS;ORAL Prescription
45MG;200MG/PACKET PELLETS;ORAL Prescription

7. Drug name - ODEFSEY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8080551 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2023

(6 months from now)

US7390791 GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US7125879 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2025

(2 years from now)

US9296769 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US8754065 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN101056673A GILEAD SCIENCES INC 4-[[4-[[4-(2-Cyanovinyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidyl]Amino] Benzonitrile Hydrochloride
Jun, 2015

(7 years ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN101816658B GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN101816658A GILEAD SCIENCES INC Pyramine Derivatives For Inhibiting Hiv
Aug, 2022

(a month ago)

CN1541215A GILEAD SCIENCES INC Hiv Inhibiting Pyrimidine Derivatives
Aug, 2022

(a month ago)

CN100509801C GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN101068597B GILEAD SCIENCES INC 4 - ((4 - ((4 - (2) -2, 6 -) Dimethylphenyl Amido) -2 - Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 11 months from now)

CN101060844B GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Sep, 2024

(1 year, 11 months from now)

CN101068597A GILEAD SCIENCES INC Fumaric Acid Salt Of 4-((4-((4-(2-Cyanovinyl)-2, 6-) Dimethylphenyl Amido)-2- Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 11 months from now)

CN101060844A GILEAD SCIENCES INC Composition Of Rt Inhibitor And Nnrti Containing Pyrimidine
Sep, 2024

(1 year, 11 months from now)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN222987B GILEAD SCIENCES INC A Pyrimidine Compound Of Formula (I)
Aug, 2022

(a month ago)

IN200400265P1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP1663240A1 GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP1663240B1 GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1632232B1 GILEAD SCIENCES INC Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP1632232A1 GILEAD SCIENCES INC Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP3808743A1 GILEAD SCIENCES INC Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761A1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP3808743B1 GILEAD SCIENCES INC Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761B1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP1789139A1 GILEAD SCIENCES INC Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1789139B1 GILEAD SCIENCES INC Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1419152B1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

EP1419152A1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7390791

(Pediatric)

GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues Oct, 2025

(3 years from now)

US8754065

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US9296769

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
200MG;EQ 25MG BASE;EQ 25MG BASE TABLET;ORAL Prescription

8. Drug name - SOVALDI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8334270 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8580765 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US9085573 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US7964580 GILEAD SCIENCES INC NA
Mar, 2029

(6 years from now)

US8633309 GILEAD SCIENCES INC Nucleoside phosphoramidates
Mar, 2029

(6 years from now)

US9284342 GILEAD SCIENCES INC Nucleoside phosphoramidates
Sep, 2030

(7 years from now)

US8618076 GILEAD SCIENCES INC Nucleoside phosphoramidates
Dec, 2030

(8 years from now)

CN102906102A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus-Containing Active Matter
Nov, 2015

(6 years ago)

CN104292256A GILEAD SCIENCES INC N - [(2 ' R) -2 '--2 '--2 ' - Methyl-Beta-Phenyl - -5 ' - Uridine Acyl] -L - Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
Nov, 2018

(3 years ago)

CN105198949A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Its Preparation Method
Dec, 2019

(2 years ago)

CN102459299A GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' - Fluoro-2'-Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine-1-Methylethyl Ester Process For Its Production
May, 2030

(7 years from now)

CN105085592A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
May, 2030

(7 years from now)

CN102459299B GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' -Fluoro-2 ' -Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine 1-Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

CN105085592B GILEAD SCIENCES INC N - [(2 ' R) - 2 ' - Deoxy-2 ' - Fluorine-2 ' - Methyl-Beta-Phenyl-5 ' - Uridine Acyl] -L - Lactamine 1-Methyl Ethyl Ester And Its Preparation Method
May, 2030

(7 years from now)

CN104017020A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

CN104017020B GILEAD SCIENCES INC Nucleoside Phosphoramidate
Mar, 2031

(8 years from now)

IN346815B GILEAD SCIENCES INC N-[ (2&Amp;Apos;R) -2&Amp;Apos; Deoxy-2&Amp;Apos;- Fluoro-2&Amp;Apos;-Methyl-Pphenyl- 5&Amp;Apos;-Uridylyl] -L-Alanine 1- Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

EP2203462B1 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2203462A2 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2826784A1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP2826784B1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP3321275A1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2913337A1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP3321275B1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2432792B1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2432792A1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2913337B1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP2609923A3 GILEAD SCIENCES INC Nucleoside Phosphoramidates
Mar, 2031

(8 years from now)

EP3290428B1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552930B1 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552931A2 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552930A2 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422A1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552931B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923B1 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923A2 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP3290428A1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9085573

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8334270

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8580765

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8889159 GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Mar, 2029

(6 years from now)

US9549941 GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Mar, 2029

(6 years from now)

US7964580

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2029

(6 years from now)

US8633309

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Sep, 2029

(6 years from now)

US8889159

(Pediatric)

GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Sep, 2029

(6 years from now)

US9549941

(Pediatric)

GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Sep, 2029

(6 years from now)

US9284342

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Mar, 2031

(8 years from now)

US8618076

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Jun, 2031

(8 years from now)

Drugs and Companies using SOFOSBUVIR ingredient

Treatment: For the treatment of hepatitis c; For the treatment of genotype 1, 2, 3 or 4 chronic hepatitis c virus (hcv) infection as a component of a combination antiviral treatment regimen with ribavirin

Dosage: PELLETS;ORAL

More Information on Dosage
Strength Dosage Availability
150MG/PACKET PELLETS;ORAL Prescription
200MG/PACKET PELLETS;ORAL Prescription

9. Drug name - STRIBILD

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7176220 GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent
Aug, 2026

(3 years from now)

US7635704 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US8981103 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US8148374 GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

CN101796040A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

CN101679325B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103275033B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B GILEAD SCIENCES INC Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN101679325A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

IN332719B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP3112355A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487161B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP2170851B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8716264 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US9457036 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US9744181 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US8592397 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US7176220

(Pediatric)

GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent Feb, 2027

(4 years from now)

US7635704

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US8981103

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US9891239 GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Sep, 2029

(6 years from now)

US8148374

(Pediatric)

GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Mar, 2030

(7 years from now)

US9891239

(Pediatric)

GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Mar, 2030

(7 years from now)

US8633219 GILEAD SCIENCES INC Combination therapy Apr, 2030

(7 years from now)

US8633219

(Pediatric)

GILEAD SCIENCES INC Combination therapy Oct, 2030

(8 years from now)

US10039718 GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

US10039718

(Pediatric)

GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Apr, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
150MG;150MG;200MG;300MG TABLET;ORAL Prescription

10. Drug name - TYBOST

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8148374 GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

CN101796040A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN101679325B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103275033B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B GILEAD SCIENCES INC Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN101679325A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN332719B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3112355A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487161B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2170851B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8148374

(Pediatric)

GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Mar, 2030

(7 years from now)

US10039718 GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

US10039718

(Pediatric)

GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Apr, 2033

(10 years from now)

Drugs and Companies using COBICISTAT ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
150MG TABLET;ORAL Prescription

11. Drug name - VEKLURY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE46762 GILEAD SCIENCES INC 1′-substituted carba-nucleoside analogs for antiviral treatment
Apr, 2029

(6 years from now)

US8318682 GILEAD SCIENCES INC 1′substituted carba-nucleoside analogs for antiviral treatment
Apr, 2029

(6 years from now)

US8008264 GILEAD SCIENCES INC 1′-substituted carba-nucleoside analogs for antiviral treatment
Sep, 2029

(6 years from now)

US10065958 GILEAD SCIENCES INC Methods and compounds for treating Paramyxoviridae virus infections
Sep, 2031

(8 years from now)

US9949994 GILEAD SCIENCES INC Methods for treating Filoviridae virus infections
Oct, 2035

(13 years from now)

US9724360 GILEAD SCIENCES INC Methods for treating Filoviridae virus infections
Oct, 2035

(13 years from now)

CN102046626A GILEAD SCIENCES INC Carba-Nucleoside Analogs For Antiviral Treatment
Sep, 2015

(7 years ago)

CN102015714A GILEAD SCIENCES INC 1'-Substituted Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

CN104262345A GILEAD SCIENCES INC 1'-Substitued Carba-Nucleoside Analog For Antiviral Therapy
Apr, 2029

(6 years from now)

CN104262345B GILEAD SCIENCES INC Antiviral Therapy For 1 ' - Substituted Carba-Nucleoside Nucleoside Analogues
Apr, 2029

(6 years from now)

CN102015714B GILEAD SCIENCES INC 1'-Substitued Carba-Nucleoside Analog For Antiviral Therapy
Apr, 2029

(6 years from now)

CN103052631B GILEAD SCIENCES INC Method And Composite For Treating Assistant Adhesive Virus Family Virus Infection
Jul, 2031

(8 years from now)

CN105343098A GILEAD SCIENCES INC Method And Composite For Treating Assistant Adhesive Virus Family Virus Infection
Jul, 2031

(8 years from now)

CN105343098B GILEAD SCIENCES INC For Treating Virus Virus Infection Of Secondary Method And Compound
Jul, 2031

(8 years from now)

CN103052631A GILEAD SCIENCES INC Method And Compound For Treating Paramyxoviridae Virus Infection
Jul, 2031

(8 years from now)

CN107073005A GILEAD SCIENCES INC Method Of Treating Filamentous Virus Family Virus Infections
Oct, 2035

(13 years from now)

CN107073005B GILEAD SCIENCES INC Method Of Treating A Virus Infection In A Filamentous Virus
Oct, 2035

(13 years from now)

IN289041B GILEAD SCIENCES INC Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

IN201301328P4 GILEAD SCIENCES INC Methods And Compounds For Treating Paramyxoviridae Virus Infections
Jul, 2031

(8 years from now)

IN319927B GILEAD SCIENCES INC Methods And Compounds For Treating Paramyxoviridae Virus Infections
Jul, 2031

(8 years from now)

EP2280973A1 GILEAD SCIENCES INC Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

EP2268642A1 GILEAD SCIENCES INC 1' -Substituted Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

EP2280973B1 GILEAD SCIENCES INC Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

EP2937350B1 GILEAD SCIENCES INC 1' -Substituted Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

EP2268642B1 GILEAD SCIENCES INC 1' -Substituted Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

EP2937350A1 GILEAD SCIENCES INC 1' -Substituted Carba-Nucleoside Analogs For Antiviral Treatment
Apr, 2029

(6 years from now)

EP2595980A1 GILEAD SCIENCES INC Methods And Compounds For Treating Paramyxoviridae Virus Infections
Jul, 2031

(8 years from now)

EP2595980B1 GILEAD SCIENCES INC Methods And Compounds For Treating Paramyxoviridae Virus Infections
Jul, 2031

(8 years from now)

EP3212174A1 GILEAD SCIENCES INC Methods For Treating Filoviridae Virus Infections
Oct, 2035

(13 years from now)

EP3366295A1 GILEAD SCIENCES INC Methods For Treating Filoviridae Virus Infections
Oct, 2035

(13 years from now)

EP3212174B1 GILEAD SCIENCES INC Methods For Treating Filoviridae Virus Infections
Oct, 2035

(13 years from now)

EP3212175B1 GILEAD SCIENCES INC Methods For The Preparation Of Ribosides
Oct, 2035

(13 years from now)

EP3212175A1 GILEAD SCIENCES INC Methods For The Preparation Of Ribosides
Oct, 2035

(13 years from now)

EP3366295B1 GILEAD SCIENCES INC Methods For Treating Filoviridae Virus Infections
Oct, 2035

(13 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11007208 GILEAD SCIENCES INC Methods for treating arenaviridae and coronaviridae virus infections Sep, 2036

(13 years from now)

US10695361 GILEAD SCIENCES INC Methods for treating arenaviridae and coronaviridae virus infections Sep, 2036

(13 years from now)

US10675296 GILEAD SCIENCES INC Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections Jul, 2038

(15 years from now)

Drugs and Companies using REMDESIVIR ingredient

Treatment: Treatment of coronavirus disease 2019 (covid-19) in non-hospitalized adults and pediatric patients (at least 12 years of age and 40 kg); treatment of coronavirus disease 2019 (covid-19) in adults and pediatric patients (at least 12 years of age and 40 kg) requiring hospitalization; Treatment of coronavirus disease 2019 (covid-19) in adults and pediatric patients (at least 12 years of age and 40 kg) requiring hospitalization; treatment of coronavirus disease 2019 (covid-19) in non-hospitalized adults and pediatric patients (at least 12 years of age and 40 kg)

Dosage: POWDER;INTRAVENOUS; SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
100MG/VIAL POWDER;INTRAVENOUS Prescription
100MG/20ML (5MG/ML) SOLUTION;INTRAVENOUS Prescription

12. Drug name - VEMLIDY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7390791 GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US9296769 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US8754065 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN101796040A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN110563747A GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2022

(3 months ago)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

CN101679325B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103435570A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103275033A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B GILEAD SCIENCES INC Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN101679325A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN107674086A GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN104995198A GILEAD SCIENCES INC Polycyclic - Carbamoyl-Pyridone Compounds And Pharmaceutical Use
Dec, 2033

(11 years from now)

CN104995198B GILEAD SCIENCES INC Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN107674086B GILEAD SCIENCES INC Polycyclic-Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof
Dec, 2033

(11 years from now)

CN106459085A GILEAD SCIENCES INC (2R, 5S, 13Ar) -7, 9 - -10-((2, 4, 6-Trifluoro-Benzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A - -2, 5-Pyridine Methylene Bridge (1 ', 2 ': 4, 5] Pyridine [2, 1-B] [1, 3] * -8 - Sodium Phenolate
Jun, 2035

(12 years from now)

CN106459085B GILEAD SCIENCES INC An Anti-Hiv Compound And Its Crystal
Jun, 2035

(12 years from now)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

IN332719B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN352932B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201918019286A GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN201505535P1 GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

IN371130B GILEAD SCIENCES INC Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP3112355A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487161B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP2170851B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP3067358A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3067358B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3608325A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954B1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP2822954A1 GILEAD SCIENCES INC Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
Dec, 2033

(11 years from now)

EP3157932A1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

EP3157932B1 GILEAD SCIENCES INC Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Jun, 2035

(12 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7390791

(Pediatric)

GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues Oct, 2025

(3 years from now)

US9296769

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US8754065

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
EQ 25MG BASE TABLET;ORAL Prescription

13. Drug name - VITEKTA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7176220 GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent
Aug, 2026

(3 years from now)

US8981103 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US7635704 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7176220

(Pediatric)

GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent Feb, 2027

(4 years from now)

US8981103

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US7635704

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

More Information on Dosage
Strength Dosage Availability
85MG TABLET;ORAL Discontinued
150MG TABLET;ORAL Discontinued

14. Drug name - VOSEVI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9585906 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8735372 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8580765 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8334270 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US9085573 GILEAD SCIENCES INC NA
Mar, 2028

(5 years from now)

US8633309 GILEAD SCIENCES INC Nucleoside phosphoramidates
Mar, 2029

(6 years from now)

US7964580 GILEAD SCIENCES INC NA
Mar, 2029

(6 years from now)

US8889159 GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus
Mar, 2029

(6 years from now)

US9284342 GILEAD SCIENCES INC Nucleoside phosphoramidates
Sep, 2030

(7 years from now)

US8618076 GILEAD SCIENCES INC Nucleoside phosphoramidates
Dec, 2030

(8 years from now)

US8940718 GILEAD SCIENCES INC Antiviral compounds
Nov, 2032

(10 years from now)

US9868745 GILEAD SCIENCES INC Antiviral compounds
Nov, 2032

(10 years from now)

US8575135 GILEAD SCIENCES INC Antiviral compounds
Nov, 2032

(10 years from now)

US8921341 GILEAD SCIENCES INC Antiviral compounds
Nov, 2032

(10 years from now)

US9296782 GILEAD SCIENCES INC Inhibitors of hepatitis C virus
Jul, 2034

(11 years from now)

CN102906102A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus-Containing Active Matter
Nov, 2015

(6 years ago)

CN104244947A GILEAD SCIENCES INC Methods And Compositions For Treating Hepatitis C Virus
Aug, 2016

(6 years ago)

CN104292256A GILEAD SCIENCES INC N - [(2 ' R) -2 '--2 '--2 ' - Methyl-Beta-Phenyl - -5 ' - Uridine Acyl] -L - Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
Nov, 2018

(3 years ago)

CN105198949A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Its Preparation Method
Dec, 2019

(2 years ago)

CN106166160A GILEAD SCIENCES INC Composition For Treating Hcv
Oct, 2021

(11 months ago)

CN102459299A GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' - Fluoro-2'-Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine-1-Methylethyl Ester Process For Its Production
May, 2030

(7 years from now)

CN102459299B GILEAD SCIENCES INC N- [ (2 ' R) -2 ' -Deoxy-2 ' -Fluoro-2 ' -Methyl-P-Phenyl-5 ' -Uridylyl] -L-Alanine 1-Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

CN105085592B GILEAD SCIENCES INC N - [(2 ' R) - 2 ' - Deoxy-2 ' - Fluorine-2 ' - Methyl-Beta-Phenyl-5 ' - Uridine Acyl] -L - Lactamine 1-Methyl Ethyl Ester And Its Preparation Method
May, 2030

(7 years from now)

CN105085592A GILEAD SCIENCES INC N-[(2 ' R)-2 '--2 '-Fluorin-2 '-De-Oxide Methyl-[Beta]-Phenyl-5 '-Uridine Acyl]-L-Alanine 1-Methyl Ethyl Ester And Preparation Method Thereof
May, 2030

(7 years from now)

CN104017020B GILEAD SCIENCES INC Nucleoside Phosphoramidate
Mar, 2031

(8 years from now)

CN104017020A GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

CN104244945A GILEAD SCIENCES INC Methods For Treating Hcv
Sep, 2032

(9 years from now)

CN104039319A GILEAD SCIENCES INC Methods And Compositions For Treating Hepatitis C Virus
Sep, 2032

(9 years from now)

CN104039319B GILEAD SCIENCES INC Composition And Method For Treating Hcv
Sep, 2032

(9 years from now)

CN104244945B GILEAD SCIENCES INC Methods For Treating Hcv
Sep, 2032

(9 years from now)

CN103328480A GILEAD SCIENCES INC A Imidazole Imidazole For Condensation Of Antiviral Composition
Nov, 2032

(10 years from now)

CN103328480B GILEAD SCIENCES INC Condensed Imidazolyl-Imidazole As Antiviral Compound
Nov, 2032

(10 years from now)

CN105837584B GILEAD SCIENCES INC Condensation Of Imidazole Imidazole As Antivirus Compound
Nov, 2032

(10 years from now)

CN105837584A GILEAD SCIENCES INC Condensed Imidazolyl-Imidazole As Antiviral Compound
Nov, 2032

(10 years from now)

CN103663345B GILEAD SCIENCES INC Microelectromechanical System (Mems) Device And Fabrication Method Thereof
Jan, 2033

(10 years from now)

CN103663345A GILEAD SCIENCES INC Microelectromechanical System (Mems) Device And Fabrication Method Thereof
Jan, 2033

(10 years from now)

CN104540832B GILEAD SCIENCES INC Type Iii Hepatitis Virus Inhibitor
Jul, 2033

(10 years from now)

CN106117309A GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

CN106117309B GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

CN104540832A GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

IN346815B GILEAD SCIENCES INC N-[ (2&Amp;Apos;R) -2&Amp;Apos; Deoxy-2&Amp;Apos;- Fluoro-2&Amp;Apos;-Methyl-Pphenyl- 5&Amp;Apos;-Uridylyl] -L-Alanine 1- Methylethyl Ester And Process For Its Production
May, 2030

(7 years from now)

IN201402598P3 GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

IN310576B GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

EP2203462B1 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2203462A2 GILEAD SCIENCES INC Nucleoside Phosphoramidate Prodrugs
Jul, 2020

(2 years ago)

EP2826784A1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP2826784B1 GILEAD SCIENCES INC Composition Comprising A Hcv Ns3 Protease Inhibitor And A Phosphoramidate Prodrug Of 2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Nucleoside
Mar, 2028

(5 years from now)

EP3321275A1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2913337A1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP3321275B1 GILEAD SCIENCES INC Crystalline Form Of Sofosbuvir
May, 2030

(7 years from now)

EP2432792B1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2432792A1 GILEAD SCIENCES INC And Process For The Preparation Of N-[(2'R)-2'-Deoxy-2'-Fluoro-2'-Methyl-P-Phenyl-5'-Uridylyl]-L-Alanine 1-Methylethyl Ester
May, 2030

(7 years from now)

EP2913337B1 GILEAD SCIENCES INC Process For The Production Of Sofosbuvir
May, 2030

(7 years from now)

EP2609923A3 GILEAD SCIENCES INC Nucleoside Phosphoramidates
Mar, 2031

(8 years from now)

EP3290428B1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552930B1 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2552931A2 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552930A2 GILEAD SCIENCES INC Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1-(2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422A1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2552931B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923B1 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2752422B1 GILEAD SCIENCES INC Stereoselective Synthesis Of Phosphorus Containing Actives
Mar, 2031

(8 years from now)

EP2609923A2 GILEAD SCIENCES INC Process For The Crystallisation Of (S)-Isopropyl 2-(((S)-(Perfluorophenoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP3290428A1 GILEAD SCIENCES INC Tablet Comprising Crystalline (S)-Isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1 (2H)-Yl)-4-Fluoro-3-Hydroxy-4-Methyltetrahydrofuran-2-Yl)Methoxy)(Phenoxy)Phosphoryl)Amino)Propanoate
Mar, 2031

(8 years from now)

EP2640719A2 GILEAD SCIENCES INC Antiviral Compounds
Nov, 2031

(9 years from now)

EP2640719B1 GILEAD SCIENCES INC Antiviral Compounds
Nov, 2031

(9 years from now)

EP2709613B2 GILEAD SCIENCES INC Methods For Treating Hcv
Sep, 2032

(9 years from now)

EP2709613A2 GILEAD SCIENCES INC Methods For Treating Hcv
Sep, 2032

(9 years from now)

EP2709613B1 GILEAD SCIENCES INC Methods For Treating Hcv
Sep, 2032

(9 years from now)

EP3431477A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP3431477B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2907816B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2635588A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2907816A1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2635588B1 GILEAD SCIENCES INC Condensed Imidazolylimidazoles As Antiviral Compounds
Nov, 2032

(10 years from now)

EP2785340A1 GILEAD SCIENCES INC Compositions And Methods For Treating Hepatitis C Virus
Nov, 2032

(10 years from now)

EP2785340B1 GILEAD SCIENCES INC Compositions And Methods For Treating Hepatitis C Virus
Nov, 2032

(10 years from now)

EP3492464A1 GILEAD SCIENCES INC Intermediates For Preparing Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

EP2870160B1 GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

EP3492464B1 GILEAD SCIENCES INC Intermediates For Preparing Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

EP2870160A1 GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

EP3159345B1 GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

EP3159345A1 GILEAD SCIENCES INC Inhibitors Of Hepatitis C Virus
Jul, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8957046 GILEAD SCIENCES INC NA Mar, 2028

(5 years from now)

US8580765

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8334270

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US8735372

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US9085573

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2028

(5 years from now)

US7964580

(Pediatric)

GILEAD SCIENCES INC NA Sep, 2029

(6 years from now)

US8633309

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Sep, 2029

(6 years from now)

US8889159

(Pediatric)

GILEAD SCIENCES INC Compositions and methods for treating hepatitis C virus Sep, 2029

(6 years from now)

US9284342

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Mar, 2031

(8 years from now)

US8618076

(Pediatric)

GILEAD SCIENCES INC Nucleoside phosphoramidates Jun, 2031

(8 years from now)

US8575135

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds May, 2033

(10 years from now)

US8921341

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds May, 2033

(10 years from now)

US8940718

(Pediatric)

GILEAD SCIENCES INC Antiviral compounds May, 2033

(10 years from now)

US11116783 GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jan, 2034

(11 years from now)

US11116783

(Pediatric)

GILEAD SCIENCES INC Combination formulation of two antiviral compounds Jul, 2034

(11 years from now)

US10912814 GILEAD SCIENCES INC Combination formulation of three antiviral compounds Jun, 2037

(14 years from now)

Drugs and Companies using SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR ingredient

Treatment: Treatment of adult patients with chronic hcv infection who have genotype 1a or 3 infection and have previously been treated with an hcv regimen containing sofosbuvir without an ns5a inhibitor; treatment of adult patients with chronic hcv infection who have genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an hcv regimen containing an ns5a inhibitor; Treatment of adult patients with chronic hcv infection who have genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an hcv regimen containing an ns5a inhibitor; treatment of adult patients with chronic hcv infection who have genotype 1a or 3 infection and have previously been treated with an hcv regimen containing sofosbuvir without an ns5a inhibitor

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
400MG;100MG;100MG TABLET;ORAL Prescription

15. Drug name - ZYDELIG

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE44638 GILEAD SCIENCES INC Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
Aug, 2025

(2 years from now)

US8865730 GILEAD SCIENCES INC Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
Mar, 2033

(10 years from now)

US10730879 GILEAD SCIENCES INC Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
Mar, 2033

(10 years from now)

US9469643 GILEAD SCIENCES INC Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
Sep, 2033

(10 years from now)

CN102229609A GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
Mar, 2013

(9 years ago)

CN104334560A GILEAD SCIENCES INC (S) -2-(1 - (9H - -6 - Ylamino) Propyl) -5--3 - Phenyl - -4 (3H) - Ketone Of Polymorph
Mar, 2017

(5 years ago)

CN106146506A GILEAD SCIENCES INC Polymorph Of (S)-2-(1-(9H-Purine-6-Ylamino)Propyl)-5-Fluorin-3-Phenyl Quinazoline-4(3H) Ketone
Apr, 2018

(4 years ago)

CN101031569B GILEAD SCIENCES INC As Human Phosphatidylinositol 3- Delta Inhibitor Quinazolinone
May, 2025

(2 years from now)

CN101031569A GILEAD SCIENCES INC Quinazolones As Human Phosphoinositide 3-Kinase Delta Inhibitor
May, 2025

(2 years from now)

EP2612862B1 GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
May, 2025

(2 years from now)

EP2612862A3 GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
May, 2025

(2 years from now)

EP3153514B1 GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
May, 2025

(2 years from now)

EP2612862A2 GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
May, 2025

(2 years from now)

EP3153514A1 GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
May, 2025

(2 years from now)

EP1761540B1 GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
May, 2025

(2 years from now)

EP1761540A1 GILEAD SCIENCES INC Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-Kinase Delta
May, 2025

(2 years from now)

EP2834241A1 GILEAD SCIENCES INC Polymorphic Forms Of (S)-2-(1-(9H-Purin-6-Ylamino)Propyl)-5-Fluoro-3-Phenylquinazolin-4(3H)-One
Mar, 2033

(10 years from now)

EP2834241B1 GILEAD SCIENCES INC Polymorphic Forms Of (S)-2-(1-(9H-Purin-6-Ylamino)Propyl)-5-Fluoro-3-Phenylquinazolin-4(3H)-One
Mar, 2033

(10 years from now)

EP2834241A4 GILEAD SCIENCES INC Polymorphic Forms Of (S)-2-(1-(9H-Purin-6-Ylamino)Propyl)-5-Fluoro-3-Phenylquinazolin-4(3H)-One
Mar, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9149477 GILEAD SCIENCES INC 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta May, 2025

(2 years from now)

US8980901 GILEAD SCIENCES INC 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta May, 2025

(2 years from now)

USRE44599 GILEAD SCIENCES INC Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta Jul, 2025

(2 years from now)

US9492449 GILEAD SCIENCES INC Therapies for hematologic malignancies Mar, 2030

(7 years from now)

Drugs and Companies using IDELALISIB ingredient

Treatment: Inhibition on pi3k kinase; For the treatment of patients with cll, fl, or sll; For the treatment of patients with cll, fl, or sll; for the treatment of patients with relapsed follicular b-cell non-hodgkin lymphoma or [relapsed] small lymphocytic lymphoma; In combination with rituximab, for the treatment of patients with relapsed chronic lymphocytic leukemia (cll)

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
100MG TABLET;ORAL Prescription
150MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.